Guardado en:
| Autor principal: | Liangwei Yin (尹良威) |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | |
| Publicado: |
Zenodo
2025
|
| Acceso en línea: | https://doi.org/10.5281/zenodo.15697455 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
por: Xiao‐Yu Zhuang, et al.
Publicado: (2024)
por: Xiao‐Yu Zhuang, et al.
Publicado: (2024)
Acanthosis Nigricans associated with clear-cell renal cell carcinoma
por: Fernando Peixoto Ferraz de Campos
Publicado: (2016)
por: Fernando Peixoto Ferraz de Campos
Publicado: (2016)
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
por: Zhan Yang, et al.
Publicado: (2024)
por: Zhan Yang, et al.
Publicado: (2024)
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
por: Wenhao Xu, et al.
Publicado: (2024)
por: Wenhao Xu, et al.
Publicado: (2024)
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
por: Motohiro Fujiwara, et al.
Publicado: (2024)
por: Motohiro Fujiwara, et al.
Publicado: (2024)
Synchronous clear cell renal cell carcinoma and classic Hodgkin lymphoma
por: Phuoc Christie‐Nguyen, et al.
Publicado: (2025)
por: Phuoc Christie‐Nguyen, et al.
Publicado: (2025)
Belzutifan's role in the treatment landscape of clear cell renal cell carcinoma
por: Adrienne H. Chen, et al.
Publicado: (2025)
por: Adrienne H. Chen, et al.
Publicado: (2025)
Identification of metabolic dysregulation and biomarkers for clear cell renal cell carcinoma
por: Bin Zheng, et al.
Publicado: (2024)
por: Bin Zheng, et al.
Publicado: (2024)
Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma
por: Steven M. Monda, et al.
Publicado: (2024)
por: Steven M. Monda, et al.
Publicado: (2024)
A multimodal deep learning framework for predicting sunitinib response in advanced clear cell renal cell carcinoma
por: Xi Tian, et al.
Publicado: (2025)
por: Xi Tian, et al.
Publicado: (2025)
Diagnostic, predictive and prognostic molecular biomarkers in clear cell renal cell carcinoma: A retrospective study
por: Jian Deng, et al.
Publicado: (2024)
por: Jian Deng, et al.
Publicado: (2024)
Multi‐instance learning for identifying high‐risk subregions associated with synchronous distant metastasis in clear cell renal cell carcinoma
por: Ling‐Feng Xue, et al.
Publicado: (2024)
por: Ling‐Feng Xue, et al.
Publicado: (2024)
Single‐cell transcriptomic analysis in clear cell renal cell carcinoma: Deciphering the role of APP within the tumour microenvironment
por: Bo Guan, et al.
Publicado: (2024)
por: Bo Guan, et al.
Publicado: (2024)
Role of tertiary lymphoid structures in the tumour microenvironment and immunotherapy response of renal cell carcinoma
por: Lin Yang, et al.
Publicado: (2025)
por: Lin Yang, et al.
Publicado: (2025)
Immunogenic cell death–related genes predict prognosis and response to immunotherapy in lung squamous cell carcinoma
por: Guoping Li, et al.
Publicado: (2024)
por: Guoping Li, et al.
Publicado: (2024)
Unravelling infiltrating T‐cell heterogeneity in kidney renal clear cell carcinoma: Integrative single‐cell and spatial transcriptomic profiling
por: Haiqing Chen, et al.
Publicado: (2024)
por: Haiqing Chen, et al.
Publicado: (2024)
Identifying genes associated with disease outcomes using joint sparse canonical correlation analysis—An application in renal clear cell carcinoma
por: Diptavo Dutta, et al.
Publicado: (2024)
por: Diptavo Dutta, et al.
Publicado: (2024)
A multimodal ensemble approach for clear cell renal cell carcinoma treatment outcome prediction
por: Chen, Meixu, et al.
Publicado: (2024)
por: Chen, Meixu, et al.
Publicado: (2024)
MFN2 suppresses the accumulation of lipid droplets and the progression of clear cell renal cell carcinoma
por: Zhiduan Cai, et al.
Publicado: (2024)
por: Zhiduan Cai, et al.
Publicado: (2024)
Comprehensive analyses of nuclear mitochondria‐related genes in the molecular features, immune infiltration, and drug sensitivity of clear cell renal cell carcinoma
por: Yuchen Zhang, et al.
Publicado: (2024)
por: Yuchen Zhang, et al.
Publicado: (2024)
CPA4 as a biomarker promotes the proliferation, migration and metastasis of clear cell renal cell carcinoma cells
por: Kongjia Wang, et al.
Publicado: (2024)
por: Kongjia Wang, et al.
Publicado: (2024)
First‐line immunotherapy of metastatic renal cell carcinoma: an updated network meta‐analysis including triplet therapy
por: Takafumi Yanagisawa, et al.
Publicado: (2024)
por: Takafumi Yanagisawa, et al.
Publicado: (2024)
Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy
por: Liang Yue, et al.
Publicado: (2024)
por: Liang Yue, et al.
Publicado: (2024)
Nc‐RNA‐mediated low expression of AZIN1 correlated with unfavorable prognosis in kidney renal clear cell carcinoma
por: Xinyi Zeng, et al.
Publicado: (2024)
por: Xinyi Zeng, et al.
Publicado: (2024)
CRYAB is upregulated and predicts clinical prognosis in kidney renal clear cell carcinoma
por: Hao Ren, et al.
Publicado: (2025)
por: Hao Ren, et al.
Publicado: (2025)
Integrative analysis of bulk and single‐cell RNA sequencing reveals sphingolipid metabolism and immune landscape in clear cell renal cell carcinoma
por: Dongdong Xie, et al.
Publicado: (2024)
por: Dongdong Xie, et al.
Publicado: (2024)
A single gene mutation predicts response to immune checkpoint blockade in ovarian clear cell carcinoma
por: Matheus Henrique Dias, et al.
Publicado: (2025)
por: Matheus Henrique Dias, et al.
Publicado: (2025)
Paraoxonase‐2 shRNA‐mediated gene silencing suppresses proliferation and migration, while promotes chemosensitivity in clear cell renal cell carcinoma cell lines
por: Valentina Schiavoni, et al.
Publicado: (2024)
por: Valentina Schiavoni, et al.
Publicado: (2024)
Adjuvant immunotherapy for high‐risk renal cell carcinoma—now or never?
por: Tivya Kulasegaran, et al.
Publicado: (2024)
por: Tivya Kulasegaran, et al.
Publicado: (2024)
CLEC18A interacts with sulfated glycosaminoglycans and controls clear cell renal cell carcinoma progression
por: Gustav Jonsson, et al.
Publicado: (2025)
por: Gustav Jonsson, et al.
Publicado: (2025)
Metastatic risk in clear cell renal cell carcinoma: a tool incorporating sex, size, and grade
por: Frederik F. Thomsen, et al.
Publicado: (2024)
por: Frederik F. Thomsen, et al.
Publicado: (2024)
Volumetric imaging of the tumor microvasculature reflects outcomes and genomic states of clear cell renal cell carcinoma
por: Yuta Kaneko, et al.
Publicado: (2024)
por: Yuta Kaneko, et al.
Publicado: (2024)
Macrophage migration inhibitory factor (MIF) predicts survival in patients with clear cell renal cell carcinoma
por: Martyna Parol‐Kulczyk, et al.
Publicado: (2024)
por: Martyna Parol‐Kulczyk, et al.
Publicado: (2024)
Comprehensive analysis of m6A methylome and transcriptome by Nanopore sequencing in clear cell renal carcinoma
por: Hexin Li, et al.
Publicado: (2024)
por: Hexin Li, et al.
Publicado: (2024)
CD2AP is a potential prognostic biomarker of renal clear cell carcinoma
por: Can Chen, et al.
Publicado: (2024)
por: Can Chen, et al.
Publicado: (2024)
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysis
por: Ei Shiomi, et al.
Publicado: (2024)
por: Ei Shiomi, et al.
Publicado: (2024)
Tumor‐associated macrophages impair NK cell IFN‐γ production and contribute to tumor progression in clear cell renal cell carcinoma
por: Sol Yanel Núñez, et al.
Publicado: (2024)
por: Sol Yanel Núñez, et al.
Publicado: (2024)
Carbonic anhydrase‐9‐targeted near‐infrared photoimmunotherapy as a theranostic modality for clear cell renal cell carcinoma
por: Hiroshi Fukushima, et al.
Publicado: (2025)
por: Hiroshi Fukushima, et al.
Publicado: (2025)
Diagnostic value of imaging in patients with clear cell papillary renal cell carcinoma: A case series and literature review
por: Yuxuan Song, et al.
Publicado: (2024)
por: Yuxuan Song, et al.
Publicado: (2024)
Papillary renal cell carcinoma with high‐ ABCC2 shows an immune‐evasive profile associated with favorable response to immunotherapy
por: Vincent Francis Castillo, et al.
Publicado: (2025)
por: Vincent Francis Castillo, et al.
Publicado: (2025)
Ejemplares similares
-
Comprehensive analysis of pain genes in prognosis of kidney renal clear cell carcinoma and tumor immunotherapy: A comprehensive bioinformatic study
por: Xiao‐Yu Zhuang, et al.
Publicado: (2024) -
Acanthosis Nigricans associated with clear-cell renal cell carcinoma
por: Fernando Peixoto Ferraz de Campos
Publicado: (2016) -
Exosome‐related lncRNA score: A value‐based individual treatment strategy for predicting the response to immunotherapy in clear cell renal cell carcinoma
por: Zhan Yang, et al.
Publicado: (2024) -
Unveiling the impact of tertiary lymphoid structures on immunotherapeutic responses of clear cell renal cell carcinoma
por: Wenhao Xu, et al.
Publicado: (2024) -
Durable response to nivolumab rechallenge in a patient with metastatic clear cell renal cell carcinoma
por: Motohiro Fujiwara, et al.
Publicado: (2024)